ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$10.89
Tradestie Score
41
Market Cap
$1.78B
Revenue Growth
-0.8%
Analyst Upside
+57.3%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$16.10
|
$3.68B | - | 53 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$98.22
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.23
|
$3.59B | 13.4 | 44 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$27.83
|
$3.58B | 12.4 | 52 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$284.47
|
$3.49B | 29.7 | 58 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.29
|
$3.40B | 119.0 | 29 | Compare |
|
QURE
uniQure N.V.
|
$44.51
|
$3.39B | - | 50 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$55.41
|
$3.33B | - | 43 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$22.80
|
$3.31B | - | 41 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
More ABCL Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry